Early Covid Treatment Symposium - Questions 6 & 7

Question #6: What other methods would you have considered as alternative pre-COVID-19, yet now you use or deem helpful for the early treatment of COVID-19?

Question #7: Has the FDA and CDC been subjected to regulatory capture such that their decisions are driven by the pharmaceutical industry's interests' instead of the public interest?
______

Bringing together thought leaders in the healthcare field to evaluate and broaden opportunities to prevent suffering and death from the Covid-19 virus. The University of Kansas Health System turned down an invitation to participate in the roundtable discussion.

Speakers:
Dr. Peter McCullough
Dr. Pierre Kory
Dr. John Littell
Dr. Jesse Lopez

Resources:
COVID-19 Treatments: https://www.kshf.org/treatments
Timeline of HCQ and IVM: https://www.kshf.org/timeline